Article Talk: The Changing Treatment Landscape of Chronic Lymphocytic Leukemia

Started by billstans, November 01, 2016
0 replies for this topic

558 Posts
Posted on
November 01, 2016
View Original Post

My wife relapsed while taking Ibrutinb after three years. She went into a clinical trial for ABT199 (Venetaclax). After 7 months she is relapsing again. She has CLL-17p. A CAR-T trial at Fred Huchinson Cancer Center in Seattle was recommended to her by her doctor at Stanford. Anybody have any thoughts?
No replies
You must log in to use this feature, please click here to login.